Adherium (ASX:ADR) Secures $2.6M to Accelerate Smartinhaler Expansion in the U.S.

2 min read | March 18, 2025 07:11 PM AEDT | By Team Kalkine Media

Adherium (ASX:ADR) Secures $2.6M to Accelerate Smartinhaler Expansion in the U.S.

Strategic Investment Fuels Growth

The latest funding round underscores the confidence investors have in Adherium’s vision. The Hailie® Smartinhaler®, a digital health solution designed to enhance medication adherence for respiratory conditions, is making strides in the U.S. market. The additional capital will help accelerate its rollout, expand patient reach, and strengthen Adherium’s position in the digital healthcare landscape.

Interim CEO and Independent Non-Executive Director Jeremy Curnock Cook expressed enthusiasm regarding the ongoing commitment of major investors. He emphasized that their support aligns with Adherium’s journey toward the wider commercialization of the Hailie® Smartinhaler® platform in the U.S., which aims to improve patient outcomes through digital monitoring of inhaler use.

Growth Trajectory and Patient Expansion

As part of its market expansion strategy, Adherium (ASX:ADR) has reaffirmed its guidance, projecting significant patient onboarding in the coming months. The company plans to onboard an additional 1,800 active patients over the next six months, with the goal of reaching 9,000 active patients by the end of 2025. This milestone would mark a substantial step forward in the company’s long-term growth plan.

Advancing Digital Healthcare Solutions

With an increasing focus on remote monitoring and digital health, Adherium’s technology provides real-time data to healthcare professionals, helping patients with chronic respiratory diseases adhere to prescribed treatment plans. The latest funding will play a crucial role in expanding access to this technology, improving patient engagement, and reinforcing Adherium’s foothold in the digital health sector.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.